Article By:
The Life Sciences Report
Thursday, March 3, 2016 7:53 AM EDT
Eden Rahim of Toronto-based Next Edge Capital describes a group of micro-, small- and mid-cap biotech names possessing powerful growth drivers that could perform even when the overall market is not so hot.
In this article: LLY, MBXBF, IBB, BIIB, REPCF, XLV, BCLI, AXON, CPHR, NTRP, SGYP, ACAD, MDVN, PTLA, ITCI, ALPMF